Life Science Investing Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
Life Science Investing Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
Homerun Resources Inc. Signs Binding LOI for the Acquisition of Additional Mineral Rights in the Santa Maria Eterna Silica Sand District